Software - Application
Compare Stocks
4 / 10Stock Comparison
TRAK vs GWRE vs VEEV vs SPNS
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Medical - Healthcare Information Services
Software - Application
TRAK vs GWRE vs VEEV vs SPNS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Software - Application | Software - Application | Medical - Healthcare Information Services | Software - Application |
| Market Cap | $185M | $11.80B | $27.35B | $2.43B |
| Revenue (TTM) | $24M | $1.34B | $3.20B | $564M |
| Net Income (TTM) | $7M | $189M | $909M | $64M |
| Gross Margin | 85.0% | 63.8% | 75.5% | 44.3% |
| Operating Margin | 30.2% | 6.8% | 28.7% | 13.7% |
| Forward P/E | 28.0x | 39.4x | 18.8x | 27.9x |
| Total Debt | $510K | $716M | $96M | $64M |
| Cash & Equiv. | $29M | $699M | $1.42B | $164M |
TRAK vs GWRE vs VEEV vs SPNS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| ReposiTrak, Inc. (TRAK) | 100 | 199.8 | +99.8% |
| Guidewire Software,… (GWRE) | 100 | 135.0 | +35.0% |
| Veeva Systems Inc. (VEEV) | 100 | 76.0 | -24.0% |
| Sapiens Internation… (SPNS) | 100 | 184.0 | +84.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TRAK vs GWRE vs VEEV vs SPNS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TRAK is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.82 vs SPNS's 1.40
- 30.9% margin vs SPNS's 11.4%
- 12.9% ROA vs GWRE's 7.2%, ROIC 21.4% vs 2.3%
GWRE is the clearest fit if your priority is growth exposure.
- Rev growth 22.6%, EPS growth 11.9%, 3Y rev CAGR 14.0%
- 22.6% revenue growth vs SPNS's 5.4%
VEEV is the clearest fit if your priority is value.
- Lower P/E (18.8x vs 27.9x), PEG 1.03 vs 1.40
SPNS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 0.45, yield 1.3%
- 301.1% 10Y total return vs VEEV's 5.2%
- Lower volatility, beta 0.45, Low D/E 13.3%, current ratio 2.24x
- Beta 0.45, yield 1.3%, current ratio 2.24x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 22.6% revenue growth vs SPNS's 5.4% | |
| Value | Lower P/E (18.8x vs 27.9x), PEG 1.03 vs 1.40 | |
| Quality / Margins | 30.9% margin vs SPNS's 11.4% | |
| Stability / Safety | Beta 0.45 vs TRAK's 1.15 | |
| Dividends | 1.3% yield, 1-year raise streak, vs TRAK's 0.9%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +49.5% vs TRAK's -52.5% | |
| Efficiency (ROA) | 12.9% ROA vs GWRE's 7.2%, ROIC 21.4% vs 2.3% |
TRAK vs GWRE vs VEEV vs SPNS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TRAK vs GWRE vs VEEV vs SPNS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SPNS leads in 3 of 6 categories
TRAK leads 2 • GWRE leads 0 • VEEV leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TRAK leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
VEEV is the larger business by revenue, generating $3.2B annually — 136.0x TRAK's $24M. TRAK is the more profitable business, keeping 30.9% of every revenue dollar as net income compared to SPNS's 11.4%. On growth, GWRE holds the edge at +24.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $24M | $1.3B | $3.2B | $564M |
| EBITDAEarnings before interest/tax | $8M | $103M | $956M | $93M |
| Net IncomeAfter-tax profit | $7M | $189M | $909M | $64M |
| Free Cash FlowCash after capex | $7M | $310M | $1.4B | $72M |
| Gross MarginGross profit ÷ Revenue | +85.0% | +63.8% | +75.5% | +44.3% |
| Operating MarginEBIT ÷ Revenue | +30.2% | +6.8% | +28.7% | +13.7% |
| Net MarginNet income ÷ Revenue | +30.9% | +14.1% | +28.4% | +11.4% |
| FCF MarginFCF ÷ Revenue | +29.1% | +23.1% | +43.7% | +12.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.7% | +24.0% | +16.0% | +11.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +13.2% | +2.6% | +23.9% | -24.2% |
Valuation Metrics
Evenly matched — TRAK and VEEV each lead in 3 of 7 comparable metrics.
Valuation Metrics
At 29.0x trailing earnings, TRAK trades at a 83% valuation discount to GWRE's 172.3x P/E. Adjusting for growth (PEG ratio), TRAK offers better value at 0.85x vs VEEV's 1.70x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $185M | $11.8B | $27.4B | $2.4B |
| Enterprise ValueMkt cap + debt − cash | $157M | $11.8B | $26.0B | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | 29.01x | 172.32x | 30.92x | 33.68x |
| Forward P/EPrice ÷ next-FY EPS est. | 28.03x | 39.38x | 18.76x | 27.85x |
| PEG RatioP/E ÷ EPS growth rate | 0.85x | — | 1.70x | 1.69x |
| EV / EBITDAEnterprise value multiple | 20.98x | 182.26x | 28.40x | 22.11x |
| Price / SalesMarket cap ÷ Revenue | 8.18x | 9.81x | 8.56x | 4.48x |
| Price / BookPrice ÷ Book value/share | 3.93x | 8.23x | 3.89x | 5.09x |
| Price / FCFMarket cap ÷ FCF | 22.01x | 39.98x | 19.33x | 33.63x |
Profitability & Efficiency
TRAK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
TRAK delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $13 for SPNS. TRAK carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to GWRE's 0.49x. On the Piotroski fundamental quality scale (0–9), SPNS scores 8/9 vs VEEV's 6/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.6% | +12.9% | +13.4% | +12.9% |
| ROA (TTM)Return on assets | +12.9% | +7.2% | +11.1% | +8.9% |
| ROICReturn on invested capital | +21.4% | +2.3% | +12.9% | +17.4% |
| ROCEReturn on capital employed | +12.9% | +2.3% | +13.8% | +16.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 6 | 8 |
| Debt / EquityFinancial leverage | 0.01x | 0.49x | 0.01x | 0.13x |
| Net DebtTotal debt minus cash | -$28M | $17M | -$1.3B | -$100M |
| Cash & Equiv.Liquid assets | $29M | $699M | $1.4B | $164M |
| Total DebtShort + long-term debt | $509,973 | $716M | $96M | $64M |
| Interest CoverageEBIT ÷ Interest expense | 165.50x | 388.85x | — | 228.41x |
Total Returns (Dividends Reinvested)
SPNS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in TRAK five years ago would be worth $21,031 today (with dividends reinvested), compared to $6,471 for VEEV. Over the past 12 months, SPNS leads with a +49.5% total return vs TRAK's -52.5%. The 3-year compound annual growth rate (CAGR) favors SPNS at 26.2% vs VEEV's -1.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.1% | -25.6% | -23.4% | — |
| 1-Year ReturnPast 12 months | -52.5% | -34.5% | -29.4% | +49.5% |
| 3-Year ReturnCumulative with dividends | +63.0% | +79.6% | -5.2% | +100.9% |
| 5-Year ReturnCumulative with dividends | +110.3% | +41.4% | -35.3% | +56.7% |
| 10-Year ReturnCumulative with dividends | +14.5% | +151.9% | +519.4% | +301.1% |
| CAGR (3Y)Annualised 3-year return | +17.7% | +21.6% | -1.8% | +26.2% |
Risk & Volatility
SPNS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
SPNS is the less volatile stock with a 0.45 beta — it tends to amplify market swings less than TRAK's 1.15 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SPNS currently trades 99.8% from its 52-week high vs TRAK's 42.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.09x | 0.50x | 0.72x | 0.45x |
| 52-Week HighHighest price in past year | $23.72 | $272.60 | $310.50 | $43.52 |
| 52-Week LowLowest price in past year | $6.94 | $115.57 | $148.05 | $26.14 |
| % of 52W HighCurrent price vs 52-week peak | +42.8% | +51.2% | +54.2% | +99.8% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 41.6 | 49.6 | 69.6 |
| Avg Volume (50D)Average daily shares traded | 161K | 1.4M | 2.3M | 0 |
Analyst Outlook
SPNS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TRAK as "Buy", GWRE as "Buy", VEEV as "Buy", SPNS as "Hold". Consensus price targets imply 136.3% upside for TRAK (target: $24) vs -12.5% for SPNS (target: $38). For income investors, SPNS offers the higher dividend yield at 1.30% vs TRAK's 0.85%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $24.00 | $245.17 | $280.10 | $38.00 |
| # AnalystsCovering analysts | 1 | 26 | 42 | 10 |
| Dividend YieldAnnual dividend ÷ price | +0.9% | — | — | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | — | — | 1 |
| Dividend / ShareAnnual DPS | $0.09 | — | — | $0.57 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.7% | 0.0% | +0.6% | 0.0% |
SPNS leads in 3 of 6 categories (Total Returns, Risk & Volatility). TRAK leads in 2 (Income & Cash Flow, Profitability & Efficiency). 1 tied.
TRAK vs GWRE vs VEEV vs SPNS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TRAK or GWRE or VEEV or SPNS a better buy right now?
For growth investors, Guidewire Software, Inc.
(GWRE) is the stronger pick with 22. 6% revenue growth year-over-year, versus 5. 4% for Sapiens International Corporation N. V. (SPNS). ReposiTrak, Inc. (TRAK) offers the better valuation at 29. 0x trailing P/E (28. 0x forward), making it the more compelling value choice. Analysts rate ReposiTrak, Inc. (TRAK) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TRAK or GWRE or VEEV or SPNS?
On trailing P/E, ReposiTrak, Inc.
(TRAK) is the cheapest at 29. 0x versus Guidewire Software, Inc. at 172. 3x. On forward P/E, Veeva Systems Inc. is actually cheaper at 18. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ReposiTrak, Inc. wins at 0. 82x versus Sapiens International Corporation N. V. 's 1. 40x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TRAK or GWRE or VEEV or SPNS?
Over the past 5 years, ReposiTrak, Inc.
(TRAK) delivered a total return of +110. 3%, compared to -35. 3% for Veeva Systems Inc. (VEEV). Over 10 years, the gap is even starker: VEEV returned +512. 1% versus TRAK's +15. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TRAK or GWRE or VEEV or SPNS?
By beta (market sensitivity over 5 years), Sapiens International Corporation N.
V. (SPNS) is the lower-risk stock at 0. 45β versus ReposiTrak, Inc. 's 1. 09β — meaning TRAK is approximately 140% more volatile than SPNS relative to the S&P 500. On balance sheet safety, ReposiTrak, Inc. (TRAK) carries a lower debt/equity ratio of 1% versus 49% for Guidewire Software, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TRAK or GWRE or VEEV or SPNS?
By revenue growth (latest reported year), Guidewire Software, Inc.
(GWRE) is pulling ahead at 22. 6% versus 5. 4% for Sapiens International Corporation N. V. (SPNS). On earnings-per-share growth, the picture is similar: Guidewire Software, Inc. grew EPS 1192% year-over-year, compared to 15. 2% for Sapiens International Corporation N. V.. Over a 3-year CAGR, VEEV leads at 14. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TRAK or GWRE or VEEV or SPNS?
ReposiTrak, Inc.
(TRAK) is the more profitable company, earning 30. 9% net margin versus 5. 8% for Guidewire Software, Inc. — meaning it keeps 30. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VEEV leads at 28. 7% versus 3. 4% for GWRE. At the gross margin level — before operating expenses — TRAK leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TRAK or GWRE or VEEV or SPNS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ReposiTrak, Inc. (TRAK) is the more undervalued stock at a PEG of 0. 82x versus Sapiens International Corporation N. V. 's 1. 40x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Veeva Systems Inc. (VEEV) trades at 18. 8x forward P/E versus 39. 4x for Guidewire Software, Inc. — 20. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TRAK: 136. 3% to $24. 00.
08Which pays a better dividend — TRAK or GWRE or VEEV or SPNS?
In this comparison, SPNS (1.
3% yield), TRAK (0. 9% yield) pay a dividend. GWRE, VEEV do not pay a meaningful dividend and should not be held primarily for income.
09Is TRAK or GWRE or VEEV or SPNS better for a retirement portfolio?
For long-horizon retirement investors, Sapiens International Corporation N.
V. (SPNS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 45), 1. 3% yield, +301. 1% 10Y return). Both have compounded well over 10 years (SPNS: +301. 1%, TRAK: +15. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TRAK and GWRE and VEEV and SPNS?
These companies operate in different sectors (TRAK (Technology) and GWRE (Technology) and VEEV (Healthcare) and SPNS (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TRAK is a small-cap quality compounder stock; GWRE is a mid-cap high-growth stock; VEEV is a mid-cap high-growth stock; SPNS is a small-cap quality compounder stock. TRAK, SPNS pay a dividend while GWRE, VEEV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.